查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534059

全球微生物產品市場

Microbial Products
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，全球微生物產品市場預計將達到2,472億美元

2023年全球微生物產品市場預估為1,932億美元，預估至2030年將達2,472億美元，2023-2030年分析期間複合年成長率為3.6%。細菌類產品是本報告分析的細分市場之一，預計複合年成長率為 4.4%，到分析期結束時將達到 1,287 億美元。分析期內，真菌類產品領域的複合年成長率預計為 3.2%。

美國市場預估526億美元，中國預期複合年成長率7.0%

預計2023年美國微生物產品市場規模將達526億美元。中國作為世界第二大經濟體，預計2030年市場規模將達520億美元，2023-2030年分析期間複合年成長率為7.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.1% 和 2.7%。在歐洲，德國的複合年成長率預計為 1.9%。

全球微生物產品市場－主要趨勢與促進因素總結

微生物產品涵蓋細菌、真菌、藻類等微生物產生的多種物質，應用於製藥、農業、食品飲料、環境管理等多種產業。在醫學上，抗生素、疫苗、酵素等微生物產品在疾病預防和治療中發揮重要作用。例如，第一種發現的抗生素青黴素是從真菌青黴菌中提取的。其他值得注意的微生物產品包括使用基因工程細菌生產的胰島素和由真菌代謝物製成並用於降低膽固醇水平的他汀類藥物。在農業領域，微生物產品被用作生物肥料和生物農藥，以促進植物生長並保護作物免受病蟲害。例如，根瘤菌促進豆類固氮，蘇力菌(Bt) 產生的毒素可有效對抗害蟲。這些化肥和農藥的環保替代品由於其永續性和減少的環境影響而越來越受歡迎。

食品和飲料產業也嚴重依賴微生物產品來生產各種發酵食品和飲料，包括優格、起司、麵包、啤酒和葡萄酒。乳酸菌、酵母菌和麴菌等微生物的發酵可提高這些產品的營養價值、風味和保存期限。此外，澱粉酶、蛋白酶和脂肪酶等微生物酶廣泛用於食品加工中，以改善質地、味道和消化率。在環境管理中，微生物產品用於生物修復過程，透過分解石油洩漏、重金屬和有機廢棄物等污染物來清理污染場地。假單胞菌、黃孢原毛平革菌等微生物有助於分解有害物質，恢復生態平衡。此外，透過可再生質能的微生物發酵生產乙醇和生物柴油等生質燃料是減少對石化燃料的依賴和減少溫室氣體排放的有前途的解決方案。

微生物產品市場的成長受到多種因素的推動。生物技術和基因工程的進步極大地增強了利用和最佳化工業應用微生物過程的能力，從而產生更有效率、更具成本效益的生產方法。對永續和環保產品不斷成長的需求正在推動微生物解決方案在農業、食品生產和環境管理中的採用。消費者的偏好也轉向天然和有機產品，從而推動了微生物食品和農業投入品的市場。此外，抗生素抗藥性細菌的增加正在推動源自微生物的新型抗生素和療法的研究和發展。政府對生物技術和環境永續性研究的措施和資助正在進一步推動市場成長。隨著這些趨勢的不斷發展，由於技術進步、監管支援以及消費者對永續性問題意識的增強，微生物產品市場預計將顯著擴大。

受訪企業範例（共86家）

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM NV
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP26682

Global Microbial Products Market to Reach US$247.2 Billion by 2030

The global market for Microbial Products estimated at US$193.2 Billion in the year 2023, is expected to reach US$247.2 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Bacterial Type Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$128.7 Billion by the end of the analysis period. Growth in the Fungi Type Products segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.6 Billion While China is Forecast to Grow at 7.0% CAGR

The Microbial Products market in the U.S. is estimated at US$52.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$52.0 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Microbial Products Market - Key Trends and Drivers Summarized

Microbial products encompass a diverse range of substances produced by microorganisms, including bacteria, fungi, and algae, which have applications across various industries such as pharmaceuticals, agriculture, food and beverages, and environmental management. In pharmaceuticals, microbial products such as antibiotics, vaccines, and enzymes play a crucial role in disease prevention and treatment. For instance, penicillin, the first antibiotic discovered, is derived from the Penicillium mold. Other notable microbial products include insulin, which is produced using genetically engineered bacteria, and statins, which are derived from fungal metabolites and used to lower cholesterol levels. In agriculture, microbial products are used as biofertilizers and biopesticides to promote plant growth and protect crops from pests and diseases. Rhizobium bacteria, for example, enhance nitrogen fixation in legumes, while Bacillus thuringiensis (Bt) produces toxins that are effective against insect pests. These environmentally friendly alternatives to chemical fertilizers and pesticides are gaining popularity due to their sustainability and reduced environmental impact.

The food and beverage industry also heavily relies on microbial products for the production of various fermented foods and beverages, such as yogurt, cheese, bread, beer, and wine. Fermentation, driven by microorganisms like Lactobacillus, Saccharomyces, and Aspergillus, enhances the nutritional value, flavor, and shelf life of these products. Moreover, microbial enzymes such as amylases, proteases, and lipases are widely used in food processing to improve texture, taste, and digestibility. In environmental management, microbial products are employed in bioremediation processes to clean up contaminated sites by breaking down pollutants like oil spills, heavy metals, and organic waste. Microorganisms such as Pseudomonas and Phanerochaete chrysosporium are instrumental in degrading toxic substances and restoring ecological balance. Additionally, the production of biofuels, such as ethanol and biodiesel, from microbial fermentation of renewable biomass offers a promising solution to reduce dependency on fossil fuels and mitigate greenhouse gas emissions.

The growth in the microbial products market is driven by several factors. Advances in biotechnology and genetic engineering have significantly enhanced the ability to harness and optimize microbial processes for industrial applications, leading to more efficient and cost-effective production methods. The increasing demand for sustainable and eco-friendly products is propelling the adoption of microbial solutions in agriculture, food production, and environmental management. Consumer preferences are also shifting towards natural and organic products, boosting the market for microbial-based foods and agricultural inputs. Furthermore, the rise in antibiotic-resistant bacteria is driving research and development of novel microbial-derived antibiotics and therapeutics. Government initiatives and funding for research in biotechnology and environmental sustainability are providing further impetus to market growth. As these trends continue to evolve, the microbial products market is poised for substantial expansion, driven by technological advancements, regulatory support, and growing consumer awareness of sustainability issues.

Select Competitors (Total 86 Featured) -

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM N.V.
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Microbial Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biotechnology and Genetic Engineering Propel Market Growth
    • Increasing Demand for Sustainable and Eco-Friendly Products Expands Addressable Market Opportunity
    • Consumer Shift towards Natural and Organic Products Drives Adoption
    • Rise in Antibiotic-Resistant Bacteria Spurs Development of Novel Microbial-Derived Therapeutics
    • Enhanced Production Methods Using Microbial Processes Strengthen Business Case for Microbial Products
    • Growing Use of Biofertilizers and Biopesticides in Agriculture Generates Demand
    • Innovations in Microbial Fermentation Techniques Accelerate Adoption in Food and Beverage Industry
    • Expansion of Bioremediation Applications Throws Spotlight on Environmental Management Solutions
    • Development of Microbial Enzymes for Industrial Applications Drives Market Growth
    • Increasing Production of Biofuels from Microbial Fermentation Expands Market Opportunities
    • Technological Advancements in Microbial Strain Improvement Enhance Product Efficacy
    • Integration of Microbial Products in Waste Management Solutions Expands Addressable Market
    • Enhanced Nutritional Value and Flavor Profiles of Fermented Foods Drives Consumer Adoption
    • Expanding Applications of Microbial Products in Pharmaceuticals Spurs Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbial Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Bacterial Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Fungi Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Viral Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CHINA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • INDIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030

IV. COMPETITION